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Protein–protein interaction (PPI) networks are associated with multiple types of biases
partly rooted in technical limitations of the experimental techniques. Another source of
bias are the different frequencies with which proteins have been studied for interaction
partners. It is generally believed that proteins with a large number of interaction partners
tend to be essential, evolutionarily conserved, and involved in disease. It has been
repeatedly reported that proteins driving tumor formation have a higher number of
PPI partners. However, it has been noticed before that the degree distribution of PPI
networks is biased toward disease proteins, which tend to have been studied more often
than non-disease proteins. At the same time, for many poorly characterized proteins no
interactions have been reported yet. It is unclear to which extent this study bias affects
the observation that cancer proteins tend to have more PPI partners. Here, we show
that the degree of a protein is a function of the number of times it has been screened
for interaction partners. We present a randomization-based method that controls for
this bias to decide whether a group of proteins is associated with significantly more
PPI partners than the proteomic background. We apply our method to cancer proteins
and observe, in contrast to previous studies, no conclusive evidence for a significantly
higher degree distribution associated with cancer proteins as compared to non-cancer
proteins when we compare them to proteins that have been equally often studied as
bait proteins. Comparing proteins from different tumor types, a more complex picture
emerges in which proteins of certain cancer classes have significantly more interaction
partners while others are associated with a smaller degree. For example, proteins of
several hematological cancers tend to be associated with a higher number of interaction
partners as expected by chance. Solid tumors, in contrast, are usually associated with
a degree distribution similar to those of equally often studied random protein sets. We
discuss the biological implications of these findings. Our work shows that accounting
for biases in the PPI network is possible and increases the value of PPI data.
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Introduction
Protein–protein interaction (PPI) networks are important
models of the functional organization of the cell. To date
many small and large scale studies exist mapping PPIs in
human (the integrated database HIPPIE; Schaefer et al., 2012,
hosts PPIs from 34,625 diﬀerent studies). However, we are still
far from the complete knowledge of the human interactome
(Venkatesan et al., 2009), especially when its (spatial and
temporal) dynamics and context-dependence are taken into
account (Ideker and Krogan, 2012; Schaefer et al., 2013). High
error rates associated with the experimental methods applied
to measure PPIs have been recognized as a major burden for
completing this goal (Von Mering et al., 2002). However, besides
experimental error, other biases pose problems on the analysis of
PPI networks.
Protein–protein interaction networks are associated with two
types of biases: technical biases caused by limitations inherent
to the experimental techniques applied to generate the PPI
networks and study biases driven by the research interests guiding
the selection of bait proteins tested for interaction partners.
Examples for technical biases are the tendency of tandem aﬃnity
puriﬁcation followed by mass spectrometry (TAP/MS) to detect
interactions between highly abundant proteins (Von Mering
et al., 2002; Björklund et al., 2008; Ivanic et al., 2009) and
interactions involving small proteins under 15 kDa (Gavin et al.,
2002). Yeast two-hybrid (Y2H) tends to detect interactions
between protein pairs located in the nucleus (Jensen and Bork,
2008).
The study bias arises due to the fact that proteins are studied
an uneven amount of times: some proteins (e.g., with higher
biomedical relevance) are studied more often than proteins with
unknown biological function. In yeast, the more GO terms a
protein is annotated to the more likely it is to be studied (Gillis
and Pavlidis, 2011; Gillis et al., 2014). This type of bias is
particularly strong in aggregated networks (Gillis et al., 2014)
as are commonly used in network biology. Not surprisingly,
highly studied proteins are associated with a higher number
of known PPI partners (their degree; Hakes et al., 2008). This
poses a major challenge on the analysis and interpretation of PPI
networks: it might misleadingly suggest a correlation between the
biological relevance of a protein and network properties as, for
example, the degree of a protein. Indeed, several studies reported
a higher degree for essential proteins (Coulomb et al., 2005) and
for disease proteins such as cancer proteins (Wachi et al., 2005;
Jonsson and Bates, 2006; Rambaldi et al., 2008). It is unclear
to which extent the reported higher degree of disease proteins
reﬂects biological properties of disease proteins in networks and
how much their degree is inﬂuenced by the fact that disease
proteins are studied more often than other proteins.
The observation that disease proteins have more interaction
partners than non-disease proteins led to numerous
computational studies using directly or indirectly the degree of a
protein as a predictor for its function or disease relation (e.g., Xu
and Li, 2006; Nie and Yu, 2013) that thereby might only reveal
highly studied proteins that are more likely to be associated to
the studied function anyway.
To avoid misleading conclusions from biased PPI networks,
it was repeatedly proposed to rely on non-biased large scale
screens for the analysis of network properties of distinct protein
classes (Zotenko et al., 2008; Rolland et al., 2014). However, the
experimental coverage of the protein set of interest is usually
low when only a single or few large scale studies are considered.
To our knowledge, there is only one study that addressed the
bias directly with a normalization strategy for the analysis of
properties of HIV targets (Dickerson et al., 2010).
Here, we ﬁrst aim to quantify the impact of the study bias
on the observed degree distribution in a large integrated PPI
network. We then investigate if one of the most frequently made
claims with respect to network properties of disease proteins, the
higher degree of cancer proteins, holds whenwe take into account
the higher number of times these proteins have been tested for
PPI partners. Surprisingly, we ﬁnd that a much more complex
picture of the degree-disease relation emerges when correcting
for the study bias, with a high heterogeneity across diﬀerent
cancer types.
Materials and Methods
Protein–Protein Interaction Data
Protein–Protein Interactions were retrieved fromHIPPIE version
1.5 (Schaefer et al., 2012). HIPPIE is an integrated PPI resource
aggregating all PPIs from various expert-curated databases.
HIPPIE implements a conﬁdence score, which reﬂects the
amount and type of evidence supporting an interaction (such
as the number of studies reporting an interaction). However,
for the purpose of this analysis we considered all 122,755
PPIs in HIPPIE as we reasoned that ﬁltering for experimental
evidence would further increase the study bias in the resulting
subnetwork. Bait usage statistics were extracted from the PPI
databases Mint (Chatr-aryamontri et al., 2007), IntAct (Kerrien
et al., 2007), and iRefWeb (Turner et al., 2010). We annotated
the number of studies in which a protein was used as a
bait.
Statistical Analyses
Statistical hypothesis testing was performed with the R statistical
computing environment. For estimating the signiﬁcance of the
Pearson correlation, the test statistic was based on Pearson’s
product moment correlation coeﬃcient. The conﬁdence interval
was based on Fisher’s Z transform. The randomization test was
performed by replacing each cancer protein by a non-cancer
protein that had been equally often tested as a bait. To obtain
reasonably distinct random protein sets we included proteins
with similar bait usage when there were fewer than four proteins
that had been tested as a bait equally often. Therefore, we
successively extended a random set with similarly often studied
proteins until the size of the set exceeded four proteins. First, we
included proteins tested as baits 20 times more or 20 times less
often than the original protein. If there were still less than four
proteins in the range we successively increased the range to 150
times tested and then to 250 times tested more or less than the
original proteins.
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Cancer Data
A recent study analyzed almost 5000 diﬀerent human cancer
exomes and their matched normal-tissue samples to detect
signiﬁcantly mutated genes in a representative selection of 21
tumor types under a uniﬁed statistical framework (Lawrence
et al., 2014). From this study, we extracted the enrichment of
somatic point mutations for each gene and tumor type. We
considered a gene a cancer gene if the enrichment q-value (the
false discovery rate adjusted equivalent to the p-value) was below
0.1 for the respective tumor type. From the 21 diﬀerent cancer
types, we analyzed 15 that were associated with at least seven
genes.
Gene Ontology Enrichment
For the GO term enrichment analysis we used the tool
ConsensusPathDB (Kamburov et al., 2011). For the analysis
of highly studied proteins, only terms below a q-value
threshold of 0.01 were considered. For the analysis of
functions associated with highly connected cancer genes, we
applied the same q-value threshold to select terms enriched
among all genes of the respective cancer and additionally
tested for the resulting terms if they were signiﬁcantly more
associated with highly connected proteins (as compared to lowly
connected).
Results
Highly Studied Proteins have More Protein
Interaction Partners
To quantify the relation between the number of times a protein
has been studied and the reported number of PPI partners, we
computed the degree of each protein from the integrated PPI
database HIPPIE (Schaefer et al., 2012). Next, we recorded how
many times each protein has been studied as a bait in studies
reporting PPIs (Figure 1A displays the fraction of proteins for
which we had information on how often they had been tested
as bait proteins). Finally, we annotated the number of PubMed
abstracts linked to each protein (as a proxy for the number
of studies reporting the protein; provided by the PubMed FTP
server; downloaded on January 8, 2015). In Figure 1B the
number of interaction partners of a protein is plotted against
the number of studies in which the protein has been tested for
interaction partners (Figure 1B shows the relation in log–log
space, Supplementary Figure S1 on linear scale). Figure 1C
visualizes the relation between the number of interaction partners
and both the number of all studies and of studies testing the
protein as a bait for interaction partners after grouping the
number of interaction partners into quartiles. As expected, the
correlation between the number of times a protein has been
tested for interaction partners as a bait protein and the interaction
degree of a protein (Pearson correlation of 0.520) is higher than
the correlation between the total number of times a protein has
been studied (including studies not focused on PPIs) and the
degree (Pearson correlation of 0.334). However, both variables
are signiﬁcantly correlated with the protein interaction degree
(p< 10−16; see Materials and Methods).
Properties of Highly Studied Proteins
Using ConsensusPathDB (Kamburov et al., 2011) we evaluated
the enrichment of functions and pathways in the set of 7114
bait proteins in terms of q-values (see Materials and Methods
for details). In accordance with a previous study that investigated
functional categories enriched among entire networks (Futschik
et al., 2007), we found a strong enrichment of proteins
with nuclear localization, or with functions in cell cycle and
metabolism (q < 10−4) among the proteins used as baits. When
calculating the enrichment of functional terms and pathways
among the 173 proteins most frequently used as a bait (at least
20 times) relative to that of the full bait list, most strongly
enriched were “pathways related to cancer” (q < 10−39). Other
strongly enriched protein classes were related to viral infection
[Hepatitis B (q < 10−28), Epstein–Barr (q < 10−21), HIV
(q < 10−17), and Herpes simplex (q < 10−15)] and signaling
pathways [TNFalpha (q < 10−28), TGFbeta (q < 10−24), and
Leptin signaling (q < 10−23)]. While the enrichment of nuclear
proteins in the entire bait set might be caused by a technical
detection bias of the still predominantly used Y2H assay, which
requires nuclear localization of the bait and prey proteins, the
strong enrichment for cancer pathways in the frequently studied
bait set clearly indicates a selection bias toward proteins with high
biomedical relevance.
Correcting for the Bait Usage Bias
To reconﬁrm the previously reported (Wachi et al., 2005;
Jonsson and Bates, 2006; Rambaldi et al., 2008) diﬀerence in
the degree distribution between cancer and non-cancer proteins,
we retrieved and pooled somatically mutated cancer genes from
21 diﬀerent tumor types (Lawrence et al., 2014). We compared
the number of PPIs of cancer proteins to the number of PPIs
of non-cancer proteins. We observed that the cancer proteins
have a signiﬁcantly higher number of PPI partners (p < 10−16;
Wilcoxon Mann–Whitney test; Figure 2A) but we suspected that
this diﬀerence could be an artifact caused by the largely diﬀerent
number of times the two protein classes have been studied for
interaction partners.
To investigate this artifact, we randomly generated sets
of non-cancer proteins equivalent (in terms of having been
studied as baits) to the set of cancer proteins. This was
done by replacing each cancer protein by a randomly selected
protein used the same number of times as a bait protein
than the cancer protein (or similar number of times if no
protein existed that was tested the exact same number of
times). For each of the 10,000 generated random sets, we
calculated the mean number of interaction partners (Figure 2B).
We found that cancer proteins tend to be involved in more
PPIs than non-cancer proteins used as baits as often as
cancer proteins. However, we did not observe a signiﬁcant
diﬀerence (a p-value computed as the fraction of times the
mean degree of the randomized set was larger than the
observed mean degree for cancer proteins; p = 0.0626). The
lack of a signiﬁcant diﬀerence between cancer proteins and
equally often studied random protein sets (as compared to the
highly signiﬁcant diﬀerence between cancer proteins and all
non-cancer proteins) suggests that previous observations on
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FIGURE 1 | (A) For slightly more than half of the proteins in HIPPIE we
had information of how often they had been tested as bait proteins for
interaction partners. (B) The number of studies in which a protein has
been tested as a bait for interaction partners is positively correlated with
the number of reported interactions (Pearson correlation of 0.520).
(C) The protein–protein interaction (PPI) degree distribution has been split
into four equally sized quartiles (1.Q–4.Q). The distribution of numbers of
all studies and only those studies testing the associated proteins as baits
for interaction partners are shown for the quartiles. Pearson correlation
values (r) are indicated.
particular network characteristics of cancer proteins are biased
by the diﬀerential research interest in disease versus non-disease
proteins.
Studying the Degree Distributions of Different
Cancers
Next we investigated if the deviation between observed and
expected degree distributions diﬀers across cancer types.
Therefore, we applied the same randomization strategy as
before to correct the study bias in the degree distributions
of cancer proteins from 15 diﬀerent tumor types (Lawrence
et al., 2014). An interesting picture emerged: while proteins
from several cancer types had close to random expectation
degree distributions, most cancers of the hematological system
had the highest deviation between mean of the observed
degree distribution and the mean of the degree distribution
of randomly sampled protein sets studied similarly often
for interaction partners (Figure 3). The highest deviations
between observed and expected degree distribution were for
chronic lymphocytic leukemia (CLL; p = 0.0248; randomization
test), diﬀuse large B-cell lymphoma (DLBCL; p = 0.0354;
randomization test) and acute myeloid leukemia (LAML;
p = 0.0525; randomization test). Interestingly, the higher degree
distribution of hematological cancer proteins is achieved by
distinct protein sets and not an artifact of overlapping cancer
protein sets: no protein was associated to these three cancers
and just three proteins appeared in association with two (see
Supplementary Table S1).
To investigate possible functional reasons for the higher
than expected by chance degree distribution of hematological
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FIGURE 2 | (A) Without correcting for the study bias the PPI degree
difference between cancer proteins and non-cancer proteins is highly
significant (∗∗∗ p < 10−16). (B) The number of PPIs is not significantly
enriched for cancer proteins as compared to equally frequently studied
random protein sets. The histogram shows the mean degree of 10,000
random gene sets with the same bait usage distribution as the cancer
protein set. The position of the red dotted line indicates the mean degree of
the cancer protein set. The p-value is computed as the fraction of times the
mean degree of the randomized set was larger than the observed mean
degree and is not significant (p = 0.0626).
cancer proteins, we computed for the proteins from those cancer
classes the ratio between the degree and the number of times
a protein had been tested as a bait protein (as a proxy for
a bias normalized degree estimate; Supplementary Table S1).
For each of the three cancer types, we focused on the 50%
of the proteins with the highest ratio. Interestingly, in two of
the cases the most highly connected proteins were indicative of
cancerogenesis processes speciﬁc to the respective hematological
tumor.
Two (RPS15 and XPO1) of the three CLL proteins with the
highest ratio of degree to experiments (out of six CLL proteins
for which we have PPI experimental data) are involved in the
establishment of ribosome localization (while none are from
the proteins with a lower ratio). The third of the highest ratio
proteins (SF3B1) is also a ribonucleoprotein. The higher degree
of the ribosome-related proteins (p = 0.05; Fisher test) is not
surprising as 100s of closely interacting proteins are involved in
the biogenesis and transport of the ribosomal subunits (Fromont-
Racine et al., 2003; Altvater et al., 2012). Interestingly, CLL cells
show impaired assembly of ribosomes (Rubin, 1971), which likely
reduces their metabolic activity and helps them to avoid cell death
(Defoiche et al., 2010).
Of the seven DLBCL proteins with the highest ratio, ﬁve
were involved in the activation of leukocytes (of a total of 13
DLBCL proteins with bait usage information). From the six
proteins with lower ratio none was associated with this function
(p < 0.05; Fisher test). Interestingly, many lymphomas resemble
gene expression patterns of activated B cells (Alizadeh et al.,
2000). Leukocyte activation has been shown to be driven by a
large and highly interconnected protein network (Calvano et al.,
2005).
The examples of ribonucleoproteins in CLL and leukocyte
activators in DLBCL illustrate how selection for tumor-speciﬁc
functions modify the observed degree distribution of each tumor.
In conclusion, there is no generally elevated connectivity of
cancer proteins. Only in some cancer types groups of proteins
tend to be mutated that belong to highly interconnected cellular
networks.
To estimate how robust our observations are with respect to
variations in the computation of the test statistic, we repeated
the randomization procedure computing the median degree of
the original and randomized protein sets instead of the mean.
The overall observation remained unchanged: random proteins
with bait usage similar to that of cancer proteins have higher
degree than random proteins without any constraints on the bait
usage (both for mean and median; Supplementary Figure S2).
However, using the median we observed a signiﬁcant degree
enrichment for cancer proteins (p < 0.01; randomization test)
and this time CLL, LAML, and BRCA had signiﬁcantly higher
number of PPIs as compared to random sets (all p < 0.05;
randomization test).
Discussion
Here, we quantify how the frequency with which a protein has
been studied for interaction partners aﬀects its reported degree
distribution. We estimate that the resulting bias is higher than
previously quantiﬁed biases resulting from technical limitations.
For example, the correlation between protein abundance and
degree ranges for diﬀerent TAP/MS networks from 0.21 to 0.46
(Ivanic et al., 2009) while we observe a correlation >0.5 between
the number of times a protein has been tested as a bait and its
degree.
Our ﬁndings have a dramatic impact on the common
understanding of the relation between protein function and
degree. Speciﬁcally, we challenge the previous ﬁnding that cancer
proteins tend to have more interaction partners than non-cancer
proteins (Wachi et al., 2005; Jonsson and Bates, 2006; Rambaldi
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FIGURE 3 | The distributions show the log2 of the mean degree of
proteins of the specific cancer type divided by the mean degree of
10,000 randomized protein sets with the same bait usage distribution
(a value of 0 would therefore signify that the mean degree of the cancer
protein set equals the observed mean degree of the random protein set,
positive values that the mean degree of the proteins of the respective
cancer type is higher than for the random set and, vice versa, negative
values that the mean degree of the random set proteins is higher as for
the proteins of the cancer type). Blue boxes indicate that the mean of the
original degree distribution of the respective cancer type is significantly higher
(p < 0.05; randomization test) as those of randomized protein sets with the
same bait usage distribution. The cancer types on the x-axis are: BLCA, bladder
cancer; BRCA, breast cancer; CLL, chronic lymphocytic leukemia; CRC,
colorectal cancer; DLBCL, diffuse large B-cell lymphoma; ESO, esophageal
adenocarcinoma; GBM, glioblastoma multiforme; HNSC, head and neck
cancer; KIRC, kidney clear cell carcinoma; LAML, acute myeloid leukemia;
LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; MEL,
melanoma; MM, multiple myeloma, and UCEC, endometrial cancer.
et al., 2008). In fact a more complex picture emerges: while some
cancer types are associated with proteins of lower or average
connectivity, others are associated with promiscuous proteins.
The diﬀerent degree distributions correlate with functional
speciﬁcities of the tumor types. Interestingly, the higher degree
distribution of hematological cancer genes is driven by largely
diﬀerent protein sets with distinct functions (the proteins
with the highest ratio between degree and bait usage are
ribonucleoproteins for CLL and proteins involved in leukocyte
activation for DLBCL).
From our analysis it follows that many cancer gene prediction
approaches might have overestimated their performance as
they directly or indirectly use the PPI degree as a feature for
classiﬁcation. A classiﬁer that preferentially selects proteins with
high degree will therefore favor highly studied proteins, which in
turn are more likely to be cancer proteins. This should be taken
into consideration by either using less biased networks from
proteome-scale screens or by omitting degree-related features for
classiﬁcation.
One limitation of the presented method is that the reported
number of times a protein has been tested as a bait gives only
a rough and a lower bound estimate as for many experiments
this information is not available in the public databases. Also,
the distinction between bait and prey protein might not apply
to all types of experimental methods (as for example for
crystallization of complexes). As described in the Results section,
our method shows a certain sensitivity with respect to the
chosen statistics. However, the overall tendency in the results
stayed the same when the median instead of the mean was
computed: randomly sampled proteins that have been studied
as often as cancer proteins are more similar in their degree
distribution to cancer proteins as to arbitrarily often studied
proteins.
In summary, we argue for the crucial importance of
taking into account the number of times a protein has been
studied when analyzing PPI networks. Ignoring the resulting
degree distribution bias is not just leading to wrong biological
assumptions on the relation between network topology and
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protein function but also introduces circularity into network-
based disease gene prediction.
To come to reliable conclusions regarding degree diﬀerences
between protein classes, it would be generally favorable if rarely
studied proteins would be increasingly often tested for PPI
partners to eliminate the diﬀerences in the very uneven bait
usage distribution. While these sharp diﬀerences persist, the here
presented methods can help to reduce the impact of the study
bias when comparing degree distributions and could be applied
to other disease protein classes.
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FIGURE S1 | The number of studies in which a protein has been tested as
a bait for interaction partners is plotted against the number of reported
interactions in linear scale.
FIGURE S2 | We randomly sampled 100 protein sets of size 10 (a) from the
cancer proteins, (b) equally often studied (as bait) non-cancer proteins,
and (c) non-cancer proteins without any constraints on the bait usage. We
computed both the mean and the median for each of the resulting 300 protein
sets. The resulting mean/median degree distributions are shown. Although with
this sampling strategy all distributions are pairwise dissimilar (∗p < 0.05;
∗∗p < 0.01; ∗∗∗p < 0.001), the random proteins that have been studied as often
as the cancer proteins have a much more similar degree distribution to the cancer
proteins as compared to randomly sampled background proteins (even though
the similarity is higher when the mean is computed than when the median is
computed).
TABLE S1 | The table shows hematological cancer proteins for which PPI
and bait usage information was available. Gene name and entrez gene id,
tumor type and the ratio between the degree and the number of times the protein
has been tested as a bait are indicated.
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